Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.Methods We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.Results In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.Conclusions/interpretation Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, many studies have shown an increase in fatty acid oxidation and β-hydroxybutyrate in individuals with MASH compared to those without liver steatosis.,38,39 likely driven by the high fatty acid flux to the liver due to Adipo-IR.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citation
Cited by
Items 101–200 of 790
Ectopic fat and cardiovascular disease: What is the link?
Gastaldelli, A., & Basta, G. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.05.005 · Cited by 162
Self-citationStatins and hepatic steatosis: Perspectives from the Dallas Heart Study
Browning, J. D. (2006) · Hepatology · doi:10.1002/hep.21248 · Cited by 162
Nikolic, D., Katsiki, N., Montalto, G., Isenovic, E., Mikhailidis, D., & Rizzo, M. (2013) · Nutrients · doi:10.3390/nu5030928 · Cited by 159
Liver fat accumulation is associated with circulating PCSK9
Ruscica, M., Ferri, N., Macchi, C., Meroni, M., Lanti, C., Ricci, C., Maggioni, M., Fracanzani, A. L., Badiali, S., Fargion, S., et al. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1188328 · Cited by 152
Zein, C. O., Lopez, R., Fu, X., Kirwan, J. P., Yerian, L. M., McCullough, A. J., Hazen, S. L., & Feldstein, A. E. (2012) · Hepatology · doi:10.1002/hep.25778 · Cited by 160
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Dongiovanni, P., Romeo, S., & Valenti, L. (2015) · BioMed Research International · doi:10.1155/2015/460190 · Cited by 150
Xin, J., Zeng, D., Wang, H., Ni, X., Yi, D., Pan, K., & Jing, B. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5752-1 · Cited by 155
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Lomonaco, R., Bril, F., Portillo-Sanchez, P., Ortiz-Lopez, C., Orsak, B., Biernacki, D., Lo, M., Suman, A., Weber, M. H., & Cusi, K. (2016) · Diabetes Care · doi:10.2337/dc15-1876 · Cited by 146
Cunha, G. M., Guzman, G., Correa De Mello, L. L., Trein, B., Spina, L., Bussade, I., Marques Prata, J., Sajoux, I., & Countinho, W. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00607 · Cited by 141
Yahoo, N., Dudek, M., Knolle, P., & Heikenwälder, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 137
VanSaun, M. N., Lee, I. K., Washington, M. K., Matrisian, L. M., & Gorden, D. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080703 · Cited by 166
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“However, many studies have shown an increase in fatty acid oxidation and b -hydroxybutyrate in individuals with MASH compared to those without liver steatosis., 38,39 likely driven by the high fatty acid fl ux to the liver due to Adipo-IR.”
Self-citationNonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
Saponaro, C., Gaggini, M., & Gastaldelli, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0607-4 · Cited by 159
Self-citationBARSHOP, N. J., SIRLIN, C. B., SCHWIMMER, J. B., & LAVINE, J. E. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03703.x · Cited by 145
Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L., Katsoulis, K., Papavassiliou, E., & Tzavara, I. (2010) · Human Reproduction · doi:10.1093/humrep/dep380 · Cited by 142
Gastaldelli, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70015-8 · Cited by 180
Self-citationInfluence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 132
Marchesini, G., & Marzocchi, R. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.013 · Cited by 149
Ferolla, S., Couto, C., Costa-Silva, L., Armiliato, G., Pereira, C., Martins, F., Ferrari, M., Vilela, E., Torres, H., Cunha, A., et al. (2016) · Nutrients · doi:10.3390/nu8070397 · Cited by 134
Meli, R., Mattace Raso, G., & Calignano, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00177 · Cited by 137
Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
Valenti, L. V. C., Riso, P., Mazzocchi, A., Porrini, M., Fargion, S. R., & Agostoni, C. V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/145421 · Cited by 151
Hepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
“Bugianesi and colleagues showed that in individuals with biopsy-proven SLD but without obesity or metabolic syndrome ( n = 12), EGP was less suppressed by insulin than in control individuals ( n = 6), and the curve insulin-EGP was shifted to the right 37 .”
Self-citationInsulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 141
Non-alcoholic steatohepatitis and metabolic syndrome
Machado, M., & Cortez-Pinto, H. (2006) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000241677.40170.17 · Cited by 133
Bisphenol A and Metabolic Syndrome: Results from NHANES
Teppala, S., Madhavan, S., & Shankar, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/598180 · Cited by 124
Nonalcoholic fatty liver disease as a multi-systemic disease
Fotbolcu, H., & Zorlu, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4079 · Cited by 130
Diabetes and liver disease: An ominous association
Moscatiello, S., Manini, R., & Marchesini, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.08.004 · Cited by 139
Wu, J., Yao, X.-Y., Shi, R.-X., Liu, S.-F., & Wang, X.-Y. (2018) · Reproductive Health · doi:10.1186/s12978-018-0519-2 · Cited by 130
Lonardo, A., & Suzuki, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051278 · Cited by 129
Bae, J. C., Cho, Y. K., Lee, W., Seo, H. I., Rhee, E., Park, S. E., Park, C., Oh, K. W., Sung, K., & Kim, B. I. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.275 · Cited by 140
Amaro, A., Fabbrini, E., Kars, M., Yue, P., Schechtman, K., Schonfeld, G., & Klein, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.039 · Cited by 125
Leite, N. C., Villela-Nogueira, C. A., Cardoso, C. R. L., & Salles, G. F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8377 · Cited by 142
The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis
Kanwar, P., & Kowdley, K. V. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.002 · Cited by 139
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia
Stadlmayr, A., Aigner, E., Steger, B., Scharinger, L., Lederer, D., Mayr, A., Strasser, M., Brunner, E., Heuberger, A., Hohla, F., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02377.x · Cited by 126
Kotronen, A., Seppälä-Lindroos, A., Bergholm, R., & Yki-Järvinen, H. (2007) · Diabetologia · doi:10.1007/s00125-007-0867-x · Cited by 126
“This finding is in keeping with previous studies in patients with non-alcoholic fatty liver disease as compared with weight-matched healthy controls [44].”
ResultDasarathy, S., Yang, Y., McCullough, A. J., Marczewski, S., Bennett, C., & Kalhan, S. C. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328345c8c7 · Cited by 124
Axelrod, C. L., Fealy, C. E., Mulya, A., & Kirwan, J. P. (2019) · Acta Physiologica · doi:10.1111/apha.13216 · Cited by 121
Liver fat and lipid oxidation in humans
Kotronen, A., Seppälä‐Lindroos, A., Vehkavaara, S., Bergholm, R., Frayn, K. N., Fielding, B. A., & Yki‐Järvinen, H. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02076.x · Cited by 115
Isokuortti, E., Zhou, Y., Peltonen, M., Bugianesi, E., Clement, K., Bonnefont-Rousselot, D., Lacorte, J.-M., Gastaldelli, A., Schuppan, D., Schattenberg, J. M., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4340-1 · Cited by 120
Self-citationGenetics of nonalcoholic fatty liver disease
Dongiovanni, P., & Valenti, L. V. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.018 · Cited by 133
Croci, I., Byrne, N. M., Choquette, S., Hills, A. P., Chachay, V. S., Clouston, A. D., O'Moore-Sullivan, T. M., Macdonald, G. A., Prins, J. B., & Hickman, I. J. (2013) · Gut · doi:10.1136/gutjnl-2012-302789 · Cited by 114
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Carvalho, C. C., Trindade, A., Duarte, A., Borralho, P. M., Machado, M. V., Cortez-Pinto, H., Rodrigues, C. M., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.172 · Cited by 113
Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep Apnea
Kheirandish-Gozal, L., Sans Capdevila, O., Kheirandish, E., & Gozal, D. (2008) · Chest · doi:10.1378/chest.07-0773 · Cited by 118
Effect of Weight Loss on Liver Free Fatty Acid Uptake and Hepatic Insulin Resistance
Viljanen, A. P. M., Iozzo, P., Borra, R., Kankaanpää, M., Karmi, A., Lautamäki, R., Järvisalo, M., Parkkola, R., Rönnemaa, T., Guiducci, L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1689 · Cited by 115
Kazankov, K., Barrera, F., Møller, H. J., Rosso, C., Bugianesi, E., David, E., Ibrahim Kamal Jouness, R., Esmaili, S., Eslam, M., McLeod, D., et al. (2016) · Liver International · doi:10.1111/liv.13150 · Cited by 113
Self-citationSaponaro, C., Sabatini, S., Gaggini, M., Carli, F., Rosso, C., Positano, V., Armandi, A., Caviglia, G. P., Faletti, R., Bugianesi, E., et al. (2022) · Liver International · doi:10.1111/liv.15377 · Cited by 116
Self-citationShojaee-Moradie, F., Cuthbertson, D. J., Barrett, M., Jackson, N. C., Herring, R., Thomas, E. L., Bell, J., Kemp, G. J., Wright, J., & Umpleby, A. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2353 · Cited by 116
Yoshitaka, H., Hamaguchi, M., Kojima, T., Fukuda, T., Ohbora, A., & Fukui, M. (2017) · Medicine · doi:10.1097/md.0000000000006712 · Cited by 114
Pioglitazone in the treatment of NASH: the role of adiponectin
Gastaldelli, A., Harrison, S., Belfort‐Aguiar, R., Hardies, J., Balas, B., Schenker, S., & Cusi, K. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04405.x · Cited by 113
Self-citationKumar, R., Rastogi, A., Sharma, M., Bhatia, V., Garg, H., Bihari, C., & Sarin, S. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113758 · Cited by 114
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Rhee, E. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.3.226 · Cited by 121
Sandhya, N., Gokulakrishnan, K., Rangasamy, S., Syed, F., Ravikumar, R., Mohan, V., & Balasubramanyam, M. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.04.003 · Cited by 118
Bernsmeier, C., Meyer-Gerspach, A. C., Blaser, L. S., Jeker, L., Steinert, R. E., Heim, M. H., & Beglinger, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087488 · Cited by 109
Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
Valenti, L., Mendoza, R. M., Rametta, R., Maggioni, M., Kitajewski, C., Shawber, C. J., & Pajvani, U. B. (2013) · Diabetes · doi:10.2337/db13-0769 · Cited by 111
Mellemkjær, A., Kjær, M. B., Haldrup, D., Grønbæk, H., & Thomsen, K. L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.11.012 · Cited by 118
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Ali, R., & Cusi, K. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 110
Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease
Perseghin, G., Bonfanti, R., Magni, S., Lattuada, G., De Cobelli, F., Canu, T., Esposito, A., Scifo, P., Ntali, G., Costantino, F., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00017.2006 · Cited by 113
Libby, A. E., Bales, E. S., Orlicky, D. J., & McManaman, J. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759795 · Cited by 118
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Fruci, B., Giuliano, S., Mazza, A., Malaguarnera, R., & Belfiore, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122933 · Cited by 107
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
Kumar, R., & Mohan, S. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00068 · Cited by 102
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Kuchay, M. S., Martínez‐Montoro, J. I., Choudhary, N. S., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Biomedicines · doi:10.3390/biomedicines9101346 · Cited by 118
Nicolson, G. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21247 · Cited by 116
Insulin resistance in development and progression of nonalcoholic fatty liver disease
Alam, S., Mustafa, G., Alam, M., & Ahmad, N. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i2.211 · Cited by 122
Bell, L. N., Wang, J., Muralidharan, S., Chalasani, S., Fullenkamp, A. M., Wilson, L. A., Sanyal, A. J., Kowdley, K. V., Neuschwander-Tetri, B. A., Brunt, E. M., et al. (2012) · Hepatology · doi:10.1002/hep.25805 · Cited by 104
Obesity-Related Digestive Diseases and Their Pathophysiology
Nam, S. Y. (2016) · Gut and Liver · doi:10.5009/gnl15557 · Cited by 113
Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice
Choi, S., Choi, Y., Choi, Y., Kim, S., Jang, J., & Park, T. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.06.028 · Cited by 114
Ferreira, D. M. S., Castro, R. E., Machado, M. V., Evangelista, T., Silvestre, A. R., Costa, A., Coutinho, J. R. H., Carepa, F., Cortez‐Pinto, H., & Rodrigues, C. M. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2130-8 · Cited by 108
RetractedGastaldelli, A., Sabatini, S., Carli, F., Gaggini, M., Bril, F., Belfort‐DeAguiar, R., Positano, V., Barb, D., Kadiyala, S., Harrison, S., et al. (2021) · Liver International · doi:10.1111/liv.15005 · Cited by 101
Self-citationHypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
Fabbrini, E., DeHaseth, D., Deivanayagam, S., Mohammed, B. S., Vitola, B. E., & Klein, S. (2009) · Obesity · doi:10.1038/oby.2008.494 · Cited by 94
Ryan, M. C., Abbasi, F., Lamendola, C., Carter, S., & McLaughlin, T. L. (2007) · Diabetes Care · doi:10.2337/dc06-2169 · Cited by 100
Seo, M., Inoue, I., Tanaka, M., Matsuda, N., Nakano, T., Awata, T., Katayama, S., Alpers, D., & Komoda, T. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2879-3 · Cited by 99
Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli, A. (2017) · Clinical Science · doi:10.1042/cs20170987 · Cited by 95
Self-citationRamezani Binabaj, M., Motalebi, M., Karimi-Sari, H., Rezaee Zavareh, M. S., & Alavian, S. M. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.23235 · Cited by 96
Jensen, V. S., Hvid, H., Damgaard, J., Nygaard, H., Ingvorsen, C., Wulff, E. M., Lykkesfeldt, J., & Fledelius, C. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0307-8 · Cited by 109
Magkos, F., Fabbrini, E., Mohammed, B. S., Patterson, B. W., & Klein, S. (2010) · Obesity · doi:10.1038/oby.2010.90 · Cited by 95
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097136 · Cited by 97
“In human patients with NAFLD/NASH, peripheral insulin resistance is a primary feature of the disease, even in lean subjects that do not present the characteristics of metabolic syndrome [34].”
BackgroundSelf-citationPathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Akhtar, D. H., Iqbal, U., Vazquez‐Montesino, L. M., Dennis, B. B., & Ahmed, A. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00028 · Cited by 105
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Ahadi, M., Molooghi, K., Masoudifar, N., Namdar, A. B., Vossoughinia, H., & Farzanehfar, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15353 · Cited by 107
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
Meroni, M., Longo, M., Fracanzani, A. L., & Dongiovanni, P. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102866 · Cited by 94
Wong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 96
Savic, D., Hodson, L., Neubauer, S., & Pavlides, M. (2020) · Nutrients · doi:10.3390/nu12082178 · Cited by 100
Dâmaso, A. R., do Prado, W. L., de Piano, A., Tock, L., Caranti, D. A., Lofrano‐Prado, M. C., Carnier, J., Christofalo, D. M. J., Lederman, H. M., Tufik, S., et al. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.09.009 · Cited by 96
Alferink, L. J. M., Trajanoska, K., Erler, N. S., Schoufour, J. D., de Knegt, R. J., Ikram, M. A., Janssen, H. L. A., Franco, O. H., Metselaar, H. J., Rivadeneira, F., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3713 · Cited by 93
Cernkovich, E. R., Deng, J., Bond, M. C., Combs, T. P., & Harp, J. B. (2008) · Endocrinology · doi:10.1210/en.2007-1148 · Cited by 87
Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
Enjoji, M., Yasutake, K., Kohjima, M., & Nakamuta, M. (2012) · International Journal of Hepatology · doi:10.1155/2012/925807 · Cited by 84
Hogg, K., Wood, C., McNeilly, A. S., & Duncan, W. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024877 · Cited by 84
Nonalcoholic fatty liver disease: a challenge for pediatricians
Widhalm, K., & Ghods, E. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.185 · Cited by 91
Metabolic and Nutritional Profile of Obese Adolescents With Nonalcoholic Fatty Liver Disease
de Piano, A., do Prado, W. L., Caranti, D. A., Siqueira, K. O., Stella, S. G., Lofrano‐Prado, M. C., Tock, L., Cristofalo, D. M. J., Lederman, H. M., Tufik, S., et al. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31803815d9 · Cited by 90
Catalase and nonalcoholic fatty liver disease
Shin, S., Cho, H.-W., Song, S.-E., & Song, D. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2195-z · Cited by 89
Rashidmayvan, M., Mohammadshahi, M., Seyedian, S. S., & Haghighizadeh, M. H. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00439-6 · Cited by 87
Moroorange juice prevents fatty liver in mice
Salomone, F., Volti, G. L., Titta, L., Puzzo, L., Barbagallo, I., Delia, F. L., Zelber-Sagi, S., Malaguarnera, M., Pelicci, P. G., Giorgio, M., et al. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3862 · Cited by 83
Männistö, V., Simonen, M., Hyysalo, J., Soininen, P., Kangas, A. J., Kamińska, D., Matte, A. K., Venesmaa, S., Käkelä, P., Kärjä, V. J., et al. (2014) · Liver International · doi:10.1111/liv.12769 · Cited by 88
Perseghin, G., Lattuada, G., COBELLI, F. D., Esposito, A., Costantino, F., Canu, T., Scifo, P., Taddeo, F. D., Maffi, P., Secchi, A., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0014-5 · Cited by 89
Bedi, O., Aggarwal, S., Trehanpati, N., Ramakrishna, G., & Krishan, P. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.10.004 · Cited by 85
Microcirculation and the Metabolic Syndrome
Wiernsperger, N. F., Nivoit, P., Kraemer‐Aguiar, L. G., & Bouskela, E. (2007) · Microcirculation · doi:10.1080/10739680701285617 · Cited by 86
Dallio, M., Sangineto, M., Romeo, M., Villani, R., Romano, A. D., Loguercio, C., Serviddio, G., & Federico, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010436 · Cited by 73
Rosso, C., Mezzabotta, L., Gaggini, M., Salomone, F., Gambino, R., Marengo, A., Saba, F., Vanni, E., Younes, R., Saponaro, C., et al. (2016) · Hepatology · doi:10.1002/hep.28287 · Cited by 76
Self-citationObesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
Hui, E., Xu, A., Yang, H. B., & Lam, K. S. L. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12093 · Cited by 88
Guerra, S., & Gastaldelli, A. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.016 · Cited by 81
Self-citation
Metadata
- Authors
- Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M.
- Affiliations
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Pisa (IT)
- Corresponding author
- Bugianesi, E.
- Venue
- Diabetologia
- Published
- 2005-03-04
- Volume
- 48
- Issue
- 4
- Pages
- 634-642
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1975388439
- Cited by
- 770
- References
- 63
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 42 · 2023: 48 · 2022: 47 · 2021: 48 · 2020: 51 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 49 · 2015: 37 · 2014: 40 · 2013: 35 · 2012: 32
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, glucose oxidation, hepatic glycogen synthesis, lipid oxidation, hepatic steatosis, adipose tissue, non-diabetic patients
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Body Composition, C-Peptide, Calorimetry, Indirect, Enzymes, Fasting, Fatty Acids, Nonesterified, Fatty Liver, Glucose, Glycerol, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, LDL, Liver, Male, Middle Aged, Oxidation-Reduction, Glucose Clamp Technique, 3-Hydroxybutyric Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.